Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
12:39:17 31/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.4279 USD | +12.60% |
|
+11.14% | -37.09% |
| Market Cap | 1.41M 1.26M 1.16M 1.05M 1.97M 133M 2.01M 13.8M 5.56M 70.45M 5.29M 5.18M 223M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -1.45M -1.29M -1.18M -1.08M -2.02M -137M -2.06M -14.14M -5.7M -72.21M -5.42M -5.31M -228M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +12.60% | ||
| 1 week | +11.14% | ||
| Current month | +0.00% | ||
| 1 month | +18.86% | ||
| 3 months | +10.37% | ||
| 6 months | -29.62% | ||
| Current year | -37.09% |
| 1 week | 0.38 |  | 0.43 |
| 1 month | 0.38 | | 0.45 |
| Current year | 0.15 | | 0.9 |
| 1 year | 0.15 | | 0.97 |
| 3 years | 0.15 | | 26.47 |
| 5 years | 0.15 | | 2,081.25 |
| 10 years | 0.15 | | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 01/08/2022 | |
David Jin
CEO | Chief Executive Officer | 36 | 31/03/2022 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 09/02/2015 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 01/08/2015 |
Jay Kranzler
CHM | Chairman | 68 | 07/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/1/26 | Free | Company | 111,209 | 3.4934% | ||
| 31/3/25 | Free | Company | 33,724 | 1.6419% | ||
| 31/12/24 | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +12.60% | +11.14% | -40.57% | -97.52% | 1.41M | |
| -2.37% | -4.19% | +39.49% | +63.21% | 63.77B | |
| -2.87% | +0.49% | +10.45% | +69.18% | 56.37B | |
| +0.62% | +2.11% | +20.22% | +102.56% | 54.62B | |
| -2.03% | -4.33% | +22.38% | +37.43% | 44.06B | |
| -1.79% | -1.98% | +16.56% | +99.68% | 42.11B | |
| -1.03% | +2.51% | +217.76% | +791.37% | 41B | |
| -5.47% | +24.76% | +98.34% | +87.34% | 34.92B | |
| +0.21% | -1.23% | +14.81% | +47.35% | 32.82B | |
| -1.70% | +18.38% | -40.68% | +341.74% | 24.7B | |
| Average | -0.37% | +8.07% | +35.88% | +154.24% | 39.43B | |
| Weighted average by Cap. | -1.79% | +5.64% | +44.98% | +164.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.25 1.15 1.05 1.96 132.92 2 13.74 5.54 70.16 5.27 5.16 221.59 |
| Net income | -11.65M -10.4M -9.55M -8.68M -16.28M -1.1B -16.61M -114M -45.96M -582M -43.73M -42.8M -1.84B | -2.91M -2.6M -2.38M -2.17M -4.06M -275M -4.15M -28.47M -11.47M -145M -10.92M -10.69M -459M |
| Net Debt | -2.59M -2.32M -2.13M -1.93M -3.62M -246M -3.7M -25.38M -10.23M -130M -9.74M -9.53M -409M | -2.86M -2.55M -2.34M -2.13M -3.99M -270M -4.07M -27.94M -11.26M -143M -10.72M -10.49M -451M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | USD 0.4279 | +12.60% | 301 |
| 28/10/26 | USD 0.3800 | -4.64% | 5,007 |
| 27/10/26 | USD 0.3985 | -3.34% | 2,115 |
| 26/10/26 | USD 0.4123 | +7.08% | 10,999 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Select your edition
All financial news and data tailored to specific country editions
